By Latika Bourke
July 22, 2018
London: An Australian company has won unprecedented US approval for a new drug to treat the second most common preventable cause of blindness in the world.
In the process, Medicines Development for Global Health, based in Melbourne, became the first not-for-profit company in the world to register a medicine with the US Food and Drug Administration.